However, various treatment methods have previously been proposed for AD, such as controlling the immune response through the inhibition of IL-2 activity, but research on treatment methods that can ultimately link compounds, diseases, and targets is still insufficient. This evidence concerns the gene IL2 and Alzheimer disease.